Weekly Digest – May 2025 Weekly Digest – May 2025 29 Apr 2025: Araris Biotech AG announces research agreement to develop next-generation ADCs using Araris’ AraLinQ technology Araris Biotech has signed a research agreement with Johnson & Johnson to develop […]
Weekly Digest – May 2025 Weekly Digest – May 2025 2 May 2025: DCx accelerates multi-modal ADC development DCx Biotherapeutics has launched with a focus on developing multi-modal antibody-drug conjugates (MM-ADCs) targeting genetically-defined cancers The company in-licensed Repare Therapeutics’ SNIPRx, […]
Weekly Digest – May 2025 Weekly Digest – May 2025 25 Apr 2025: Chinese biotech inks ADC platform deal with ConjugateBio Escugen has signed an exclusive option agreement with ConjugateBio to license its EZWi-Fit platform for next-generation antibody-drug conjugates (ADCs) […]
